The aim of this study was to evaluate the expression levels of MCP-4 and eotaxin-3 in patients with COPD and investigate whether the production of these cytokines was associated with the inflammation and development of this disease. The gene discussed is CCL13; the disease is chronic obstructive pulmonary disease.